معرفی
Dr. Andrew Edwards is an Associate Professor in Molecular Microbiology at Imperial College London's Faculty of Medicine, affiliated with the Department of Infectious Disease and multiple research centers including the Centre for Bacterial Resistance Biology and Microbiome Network. His research focuses on antibiotic mechanisms, bacterial resistance/tolerance, and novel therapeutic development. Key themes include polymyxin antibiotic efficacy, colistin resistance mechanisms, host environment impacts on antibiotic susceptibility, and drug delivery innovations. He collaborates across disciplines (chemistry, bioengineering) to combat drug-resistant pathogens.
His work combines molecular microbiology with clinical relevance, addressing urgent global health challenges like antibiotic resistance. Research highlights include elucidating colistin's membrane-targeting action, studying heteroresistance in hospital pathogens, and developing glatiramer acetate as an antibiotic resistance breaker. Recent studies investigate how human serum and host stresses alter bacterial antibiotic responses.
Edwards' lab has published extensively on daptomycin resistance, Staphylococcus aureus survival strategies, and nanotechnology-based drug delivery systems. Collaborations with Imperial's Health Protection Research Unit strengthen translational research. No awards are explicitly mentioned, though his work aligns with high-impact microbiology priorities.
He advises on grants related to bacterial stress responses and therapeutic development. Affiliations with the Institute of Infection and Molecular Microbiology Section position him at the forefront of infectious disease research.
